Large gap with delayed quotes
Analysis date: 09.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 09.12.2025.
Interest
Very weak
Very weak
One star since 09.12.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 09.12.2025 at a price of 51.57.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 21.11.2025.
4wk Rel Perf
-14.82%
-14.82%
The four-week dividend-adjusted underperformance versus STOXX600 is 14.82%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 25.11.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.48%.
Mkt Cap in $bn
130.50
130.50
With a market capitalization >$8bn, PROSUS is considered a large-cap stock.
G/PE Ratio
1.29
1.29
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.75
11.75
The estimated PE is for the year 2028.
LT Growth
14.76%
14.76%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.36%
0.36%
The twelve month estimated dividend yield represents 4.21% of earnings forecasts.
Beta
141
141
For 1% of index variation, the stock varies on average by 1.41%.
Correlation
0.64
0.64
64.26% of stock movements are explained by index variations.
Value at Risk
6.27
6.27
The value at risk is estimated at EUR 6.27. The risk is therefore 12.15%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.12.2019
03.12.2019